Overview
IART market data
Price History
IART price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$6.74 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.24 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -0.4% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $8.70 – $20.49 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.4B · P/B 0.93 · P/S 0.85.
Company News
Integra Lifesciences shares are trading higher after Wells Fargo raised its price target on the stock from $15 to $18.Benzinga · Jul 30, 2026, 4:55 PM
Wells Fargo Maintains Equal-Weight on Integra Lifesciences, Raises Price Target to $18Benzinga · Jul 30, 2026, 1:58 PM
Integra LifeSciences shares are trading lower. The company reported Q2 financial results and lowered its FY26 sales guidance.Benzinga · Jul 29, 2026, 2:53 PM
8-K filing — INTEGRA LIFESCIENCES HOLDINGS CORP (IART)SEC EDGAR · Jul 29, 2026, 10:15 AM
Integra Lifesciences Sees Q3 Adj EPS $0.53-$0.61 vs $0.56 Est; Sees Sales $410.000M-$425.000M vs $418.100M EstBenzinga · Jul 29, 2026, 10:08 AM
Integra Lifesciences Affirms FY2026 Adj EPS Guidance of $2.40-$2.50 vs $2.45 Est; Lowers FY2026 Sales Guidance from $1.662B-$1.702B to $1.654B-$1.695B vs $1.676B EstBenzinga · Jul 29, 2026, 10:07 AM
Integra Lifesciences Q2 Adj. EPS $0.56 Beats $0.48 Estimate, Sales $418.761M Beat $418.647M EstimateBenzinga · Jul 29, 2026, 10:00 AM
UBS Initiates Coverage On Integra Lifesciences with Neutral Rating, Announces Price Target of $19Benzinga · Jul 28, 2026, 6:21 PM
Ultrasonic Aspirator Market Size Projected to Reach USD 376.32 Million by 2035 | SNS InsiderGlobenewswire Inc · Jul 28, 2026, 11:15 AM
Truist Securities Maintains Hold on Integra Lifesciences, Raises Price Target to $19Benzinga · Jul 16, 2026, 4:10 PM